Spider Rock Advisors, LLC Amgen Inc Call Options Transaction History

Spider Rock Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $129,828 - $154,602	600 Added 30.0%	2,600 $663,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $364,480 - $483,400	2,000 New	2,000 $4,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $978,982 - $1.09 Million	-5,800 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $970,282 - $1.11 Million	5,800	5,800 $48,000

3,079

405M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.